DK146690C - Analogifremgangsmaade til fremstilling af 9alfa,11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion - Google Patents
Analogifremgangsmaade til fremstilling af 9alfa,11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dionInfo
- Publication number
- DK146690C DK146690C DK321180A DK321180A DK146690C DK 146690 C DK146690 C DK 146690C DK 321180 A DK321180 A DK 321180A DK 321180 A DK321180 A DK 321180A DK 146690 C DK146690 C DK 146690C
- Authority
- DK
- Denmark
- Prior art keywords
- oxycarbonyldicyclohexylmethyloxypregna
- 9alfa
- 16alfa
- 11beta
- dichlor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
- C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
- C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7919296 | 1979-07-26 | ||
FR7919296A FR2462443A1 (fr) | 1979-07-26 | 1979-07-26 | Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament |
Publications (3)
Publication Number | Publication Date |
---|---|
DK321180A DK321180A (da) | 1981-01-27 |
DK146690B DK146690B (da) | 1983-12-05 |
DK146690C true DK146690C (da) | 1984-05-21 |
Family
ID=9228325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK321180A DK146690C (da) | 1979-07-26 | 1980-07-25 | Analogifremgangsmaade til fremstilling af 9alfa,11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion |
Country Status (20)
Country | Link |
---|---|
US (1) | US4353899A (fi) |
JP (1) | JPS5622798A (fi) |
AT (1) | AT371483B (fi) |
AU (1) | AU528292B2 (fi) |
BE (1) | BE884494A (fi) |
CA (1) | CA1141751A (fi) |
CH (1) | CH645389A5 (fi) |
DE (1) | DE3028255C2 (fi) |
DK (1) | DK146690C (fi) |
FI (1) | FI66880C (fi) |
FR (1) | FR2462443A1 (fi) |
GB (1) | GB2054600B (fi) |
HU (1) | HU180364B (fi) |
IE (1) | IE50031B1 (fi) |
IT (1) | IT1145302B (fi) |
MX (1) | MX6649E (fi) |
NL (1) | NL8004282A (fi) |
NO (1) | NO153102C (fi) |
SE (1) | SE447387B (fi) |
ZA (1) | ZA803867B (fi) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2533928A1 (fr) * | 1982-10-05 | 1984-04-06 | Roussel Uclaf | Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments |
FR2561919B1 (fr) * | 1984-04-03 | 1986-12-19 | Roussel Uclaf | Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon |
DE19932511A1 (de) * | 1999-07-12 | 2001-01-18 | Helmig Hans Gmbh | Schaltvorrichtung für eine Kettengangschaltung zur Betätigung der Kettenradgruppe an der Tretkurbel eines Fahrrades |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL122815C (fi) * | 1963-12-19 | |||
FR2342738A1 (fr) * | 1976-03-02 | 1977-09-30 | Roussel Uclaf | Nouveaux derives halogenes de la serie du 16a-methyl pregnane |
FR2381065A2 (fr) * | 1977-02-22 | 1978-09-15 | Roussel Uclaf | Nouveaux derives halogenes de la serie du 16 a-methyl pregnane |
-
1979
- 1979-07-26 FR FR7919296A patent/FR2462443A1/fr active Granted
-
1980
- 1980-06-13 SE SE8004428A patent/SE447387B/sv not_active IP Right Cessation
- 1980-06-19 HU HU80801526A patent/HU180364B/hu not_active IP Right Cessation
- 1980-06-26 ZA ZA00803867A patent/ZA803867B/xx unknown
- 1980-07-01 FI FI802092A patent/FI66880C/fi not_active IP Right Cessation
- 1980-07-15 MX MX808920U patent/MX6649E/es unknown
- 1980-07-15 IT IT49248/80A patent/IT1145302B/it active
- 1980-07-22 CA CA000356705A patent/CA1141751A/fr not_active Expired
- 1980-07-25 CH CH573280A patent/CH645389A5/fr not_active IP Right Cessation
- 1980-07-25 NO NO802256A patent/NO153102C/no unknown
- 1980-07-25 NL NL8004282A patent/NL8004282A/nl not_active Application Discontinuation
- 1980-07-25 DK DK321180A patent/DK146690C/da active
- 1980-07-25 JP JP10142880A patent/JPS5622798A/ja active Granted
- 1980-07-25 AU AU60811/80A patent/AU528292B2/en not_active Ceased
- 1980-07-25 BE BE0/201544A patent/BE884494A/fr not_active IP Right Cessation
- 1980-07-25 IE IE1561/80A patent/IE50031B1/en unknown
- 1980-07-25 DE DE3028255A patent/DE3028255C2/de not_active Expired
- 1980-07-28 AT AT0391380A patent/AT371483B/de not_active IP Right Cessation
- 1980-07-28 GB GB8024660A patent/GB2054600B/en not_active Expired
-
1981
- 1981-09-08 US US06/300,252 patent/US4353899A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO153102B (no) | 1985-10-07 |
FR2462443B1 (fi) | 1982-12-31 |
HU180364B (en) | 1983-02-28 |
JPS5622798A (en) | 1981-03-03 |
IT8049248A0 (it) | 1980-07-15 |
FI802092A (fi) | 1981-01-27 |
IT1145302B (it) | 1986-11-05 |
SE8004428L (sv) | 1981-01-27 |
IE801561L (en) | 1981-01-26 |
SE447387B (sv) | 1986-11-10 |
IE50031B1 (en) | 1986-02-05 |
GB2054600B (en) | 1983-02-02 |
NL8004282A (nl) | 1981-01-28 |
CH645389A5 (fr) | 1984-09-28 |
NO153102C (no) | 1986-01-15 |
US4353899A (en) | 1982-10-12 |
GB2054600A (en) | 1981-02-18 |
CA1141751A (fr) | 1983-02-22 |
BE884494A (fr) | 1981-01-26 |
AU6081180A (en) | 1981-01-29 |
ATA391380A (de) | 1982-11-15 |
DK321180A (da) | 1981-01-27 |
FR2462443A1 (fr) | 1981-02-13 |
FI66880B (fi) | 1984-08-31 |
DE3028255A1 (de) | 1981-02-19 |
NO802256L (no) | 1981-01-27 |
ZA803867B (en) | 1981-06-24 |
DK146690B (da) | 1983-12-05 |
DE3028255C2 (de) | 1985-12-19 |
JPS6254438B2 (fi) | 1987-11-14 |
MX6649E (es) | 1985-10-01 |
AU528292B2 (en) | 1983-04-21 |
AT371483B (de) | 1983-06-27 |
FI66880C (fi) | 1984-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK158788C (da) | Analogifremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater | |
DK408580A (da) | Fremgangsmaade til fremstilling af 1,8-naphthydridinforbindelser | |
DK161147C (da) | Analogifremgangsmaade til fremstilling af oe3haa-imidazo-oe5,1-daa-1,2,3,5-tetrazin-4-onderivater | |
DK146962C (da) | Analogifremgangsmaade til fremstilling af indolizinderivater | |
DK155669C (da) | Analogifremgangsmaade til fremstilling af pleuromutilinderivater | |
DK46777A (da) | Fremgangsmade til fremstilling af meta-aryloxybenzaldehyder | |
DK163580C (da) | Analogifremgangsmaade til fremstilling af cyclohexancarboxylsyrederivater | |
DK148538C (da) | Analogifremgangsmaade til fremstilling af 2,3-substituerede 4-pyroner | |
DK151256C (da) | Analogifremgangsmaade til fremstilling af alkylendioxybenzenderivater | |
DK233377A (da) | Fremgangsmade til fremstilling af omega-noraromatiske-13,14-dehydro-prostaglandiner | |
DK156635C (da) | Analogifremgangsmaade til fremstilling af 24,24-difluor-25-hydroxycholecalciferol | |
DK154434C (da) | Analogifremgangsmaade til fremstilling af tripeptidderivater | |
DK148302C (da) | Analogifremgangsmaade til fremstilling af 1,3-dialkylxanthinderivater | |
DK146017C (da) | Analogifremgangsmaade til fremstilling af 17alfa-acyloxy-9alfa,21-dihalogen-11beta-hydroxy-6alfa-fluor-16beta-methyl-pregna-1,4-dien-3,20-dion-forbindelser | |
DK156399C (da) | Analogifremgangsmaade til fremstilling af spiro-quinolylhydantoin-derivater | |
DK146690C (da) | Analogifremgangsmaade til fremstilling af 9alfa,11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion | |
DK566277A (da) | Fremgangsmaade til fremstilling af 1-aminoalkyl3,4-diphenyl-1h-pyrazoler | |
DK301177A (da) | Fremgangsmade til fremstilling af 6a,10a-cishexahydrodibenzopyranoner | |
DK29276A (da) | Fremgangsmade til fremstilling af 8-bromothieno-triazolo-1,4-diazepiner | |
DK150156C (da) | Analogifremgangsmaade til fremstilling af carbostyrilderivater | |
DK145578C (da) | Analogifremgangsmaade til fremstilling af klormetyl-17alfa-acetoxy-9alfa-fluor-11beta-hydroxy-16beta-metyl-3-oxoandrosta-1,4-dien-17beta-karboxylat | |
DK146129C (da) | Analogifremgangsmaade til fremstilling af ergopeptidalkaloidderivater | |
DK149185C (da) | Analogifremgangsmaade til fremstilling af trialkylsilylpropionsyreamider | |
DK233180A (da) | Fremgangsmaade til fremstilling af 8-fluordibenzo (b,f) thiepiner | |
DK36679A (da) | Stereospecifik fremgangsmaade til fremstilling af d,1-erythro-og d,1-threo-2-oxiranyl-1,4-benzodioxaner |